StageZero Life Sciences Ltd.
SZLS.TO
TSX
| Weiss Ratings | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.01 | |||
| Price History | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | 0.00% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -11.11% | |||
| 2-Year Total Return | -68.00% | |||
| 3-Year Total Return | -79.49% | |||
| 5-Year Total Return | -83.33% | |||
| 52-Week High % Change | -27.27% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.06 | |||
| 52-Week Low Price | $0.04 | |||
| 52-Week Low Price (Date) | Mar 14, 2024 | |||
| 52-Week High Price (Date) | Mar 27, 2024 | |||
| Valuation | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 3.42M | |||
| Enterprise Value | 5.41M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -90.33% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.51 | |||
| Price/Book (Q) | -0.44 | |||
| Enterprise Value/Revenue (TTM) | 3.52 | |||
| Price | $0.04 | |||
| Enterprise Value/EBITDA (TTM) | -3.92 | |||
| Enterprise Value/EBIT | -3.70 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 123.53M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 70 East Beaver Creek Road Richmond Hill, ON L4B 3B2 | |||
| Website | www.stagezerolifesciences.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.01 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -32.97% | |||
| Earnings Growth (Q YOY) | 51.42% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | 60.49% | |||
| Balance Sheet | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 15.00K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 235.00K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -11.13M | |||
| Current Ratio (Q) | 0.023 | |||
| Book Value Per Share (Q) | -$0.09 | |||
| Total Assets (Q) | 580.70K | |||
| Total Current Liabilities (Q) | 10.33M | |||
| Total Debt (Q) | 2.13M | |||
| Total Liabilities (Q) | 11.71M | |||
| Total Common Equity (Q) | -11.13M | |||
| Cash Flow | SZLS.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
